Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v3-FR
Language French French
Date Updated 2021-07-08 2021-04-27
Drug Identification Number 02024179 02024179
Brand name OCTOSTIM LIQ INJ. 15MCG/ML OCTOSTIM LIQ INJ. 15MCG/ML
Common or Proper name Desmopressin Acetate Injection Desmopressin Acetate Injection
Company Name FERRING INC FERRING INC
Ingredients DESMOPRESSIN ACETATE DESMOPRESSIN ACETATE
Strength(s) 15MCG 15MCG
Dosage form(s) LIQUID SOLUTION LIQUID SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size Cartons of 10 ampoules Cartons of 10 ampoules
ATC code H01BA H01BA
ATC description POSTERIOR PITUITARY LOBE HORMONES POSTERIOR PITUITARY LOBE HORMONES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-04-30 2021-04-30
Actual discontinuation date 2021-04-29
Remaining supply date 2021-04-29 2021-04-30
Discontinuation status Reversed To be discontinued
Discontinuation decision reversal yes no
Tier 3 Status No No
Information on remaining supply
Company comments For patients, please discuss alternative treatment options with your health care professional. For patients, please discuss alternative treatment options with your health care professional.
Health Canada comments